Evidence map›Paper›PMID 41924661›Full record

ArticleCureus2026

Contaminants in an Over-the-Counter Medication and Their Effect on Rheumatoid Arthritis Diagnosis: A Case Report.

Arzoo Manandhar, Lakshmi Sadasivam

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Arzoo ManandharInternal Medicine, University of California Los Angeles, David Geffen School of Medicine, Los Angeles, USA.
Lakshmi SadasivamMedicine, University of California Los Angeles, David Geffen School of Medicine, Los Angeles, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease. Early diagnosis and intervention are critical, and contaminated medications can complicate or obscure the diagnosis of autoimmune diseases. Herein, we report a case of a 38-year-old man who presented with two to three months of worsening arthralgias and myalgias. He reported using AK Forte, a natural supplement from Mexico that was recalled by the FDA for contamination with diclofenac, dexamethasone, and methocarbamol. AK Forte is a popular supplement used in Latin America, especially amongst manual laborers and other physically demanding job workers, and is easily accessible over the counter. The patient also reported Cushingoid symptoms such as weight gain, facial puffiness, and stretch marks. Upon abruptly discontinuing AK Forte, the patient presented to the emergency department with worsening arthralgias, myalgias, intermittent fever, and tachycardia. Despite being on a supplement contaminated with steroids, the patient did not present with symptoms of adrenal insufficiency throughout his hospital course. After ruling out infectious causes, the patient was diagnosed with persistent sinus tachycardia associated with high RA inflammatory activity. This case demonstrates the importance of obtaining a thorough medication history, including over-the-counter drugs, vitamins, and herbal supplements. This case also highlights the risks associated with unregulated supplements, especially those sold outside the United States, as they may not adhere to FDA standards and may be contaminated with pharmacologically active ingredients, affecting their safety, efficacy, and quality.

Indexed as

adrenal insufficiencyak forteartri kingcontaminantsdietary and herbal supplementsherbal supplementsiatrogenic cushingiatrogenic cushing’s syndromemedication causing adrenal insufficiencyunregulated supplements

Identifiers

PMID41924661
PMCPMC13038237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.